Projetos

FFULisboa enquanto Instituição ProponenteFFULisboa enquanto Instituição Participante

 

  • FFULisboa enquanto Instituição Proponente

 

Referência

Investigador Responsável

Título

Duração

PTDC/SAU-FCF/101950/2008

 

Luís Filipe Vicente Constantino A new life for old antimycobacterial drugs: development of prodrugs of pyrazinoic acid activated by mycobacterial esterases as a way to circumvent resistance to pyrazinamide 2010-2013
PTDC/SAU-FCF/098733/2008 Helena Maria Cabral Marques Lung CYD-DDS (cyclodextrin-based drug delivery systems) for inhalation 2010-2013
PTDC/CVT/098290/2008  Maria Eugénia Meirinhos Cruz A challenge for the treatment of parasitic diseases: rational design of trifluralin derivatives and appropriate nanoformulations 2009-2013
PTDC/EBB-BIO/101237/2008 António José Leitão Neves Almeida The use of nanobiomaterials for structural and funcional protection of human phenylalanine hydroxylase: towards a new approach to phenylketonuria treatment 2010-2013
PTDC/SAU-FCF/098733/2008 Helena Maria Cabral Marques Lung CYD-DDS (cyclodextrin-based drug delivery systems) for inhalation 2010-2013

PTDC/CVT/098290/2008

Maria Eugénia Meirinhos da Cruz

A challenge for the treatment of parasitic diseases: rational design of Trifluralin derivatives and appropriate nanoformulations 2010-2013
EXCL/CTM-NAN/0166/2012  Ana Francisca Campos Simão Bettencourt Polinanobiofilm – Polymeric therapeutic nanoparticles containing an antimicrobial agent: new opportunities for the development of anti-biofilm agents to treat prostetic joint infections  2010-2013
PGG/029/2013
António José Leitão Neves Almeida DUALBIOSOME – Estratégia nanotecnológica para o tratamento de infecções pulmonares crónicas em doentes com fibrose quística. Programa Gilead Génese 2013-2014
EXPL/CVT-EPI-0862/2012 Manuela Colla Carvalheiro Cutaneous Leishmaniasis: an innovative idea to explore the topical treatment of skin lesions 2013-2014
PTDC/EBB-EBI/119860/2010  António José Leitão Neves Almeida Helicobacter pylori phages: translating an understanding phenomenon into a therapeutic application 2012-2015
PTDC /BBB-BQB/0506/2012 Liana Casquinha da Silva Ceramide-Platforms: implication of membrane biophysical properties on ceramide biological outcome. 2013-2015
EXPL/DTP-FTO/0308/2013  Sandra Isabel Dias Simões PRIMED-UCX – Priming of Mesenchymal Stromal C ells from the Umbilical C ord Tissue (UC X®) as a Means of Incrementing Their Therapeutic Potency for Rheumatoid Arthritis 2014-2015
João Pedro Almeida Lopes Evaluation of the ability of near-infrared spectroscopy to determine multiple properties of cereals and feedstock. Funded by SOJA DE PORTUGAL SA, Portugal Feb2015-Jul2015
PGG/037/2014 Helena Isabel Fialho Florindo COMBI-VIH: Multivalent nanoplatform for immune modulation to control HIV/AIDS infection. Gilead Program  2015
Paulo Roque Lino Human phenylalanine hydroxlase and nanobiomaterials: A novel enzyme reposition therapy approach to PKU. Source: The National PKU Alliance (NPKUA), USA. 2015-2017
UTAP-ICDT/DTP-FTO/0016/2014 Helena Isabel Fialho Florindo MultiNanoVac: Multidisciplinary Strategy to Develop Novel Multicomponent Nanoscale Systems for Immune Modulation 2015-2018
Proj. 6818 FCT/DAAD 2015/2016) Acções integradas Luso-Alemães entre a FFULisboa e o Centro para Biofilmes Infecções, Charité-Universitätsmedizin Berlin (Dr Annette Moter)  Lídia Maria Diogo Gonçalves “NanoBioFISH – Caracterização da actividade de antibióticos nanoencapsulados contra biofilmes bacterianos por hibridação fluorescente in situ (FISH)” 2016-2017
PTDC/BBBBEP/2463/2014  Susana Lucas “ProbeCOPD. Protease activity based probes for Chronic Obstructive Pulmonary Disease diagnostics” 2016-2019
QREN I&DT CoPromoção nº38749 “Arroz+” Empresa promotora :Novarroz, Produtos Alimentares SA. Medida  A4. Avaliação (in vivo) do potencial de redução colesterol, da capacidade antioxidante e anti-inflamatória do farelo desengordurado 2014-2015
Maria Luísa Teixeira Azevedo Rodrigues Corvo Biopharmaceuticals Formulations for Dry Powder Inhaler Hovione 2015-2018
Maria Luísa Teixeira Azevedo Rodrigues Corvo Dissolution of Dry Powder Inhaler formulations: in vitro/in vivo correlations Hovione 2015-2018
Andreia Patrícia Henriques Ascenso “Effects of water depleted from heavy isotopes of oxygen and hydrogen on physical properties (solubilisation and electrical conductivity) and penetration of plant-derived polyphenols through cutaneous barrier” Empresa promotora MEDENA Ltd;
João Pedro Almeida Lopes Development of an high-throughput system for evaluating cork disks quality for in-process implementation Início: fevereiro de 2016
PTDC/BBB-BQB/3710/2014 Liana Casquinha da Silva Atyp-SLs: Biophysical and biological properties of atypical sphingolipids: implications to physiology and pathophysiology 2016-2019
ENMeedd//00000033//22001155 Rogério Paulo Pinto de Sá Gaspar NanoTumim – Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy. 2016-2019

PTDC/CTM/098688/2008

João Fernandes Abreu Pinto

Produção de coextrudidos contendo polimorfos de micro e nanopartículas de fármacos para penso transdérmico e laminado oral

PTDC/EBB-BIO/101237/2008

António José Leitão Neves Almeida

Aplicação de nanobiomateriais para preservação estrutural e funcional da fenilalanina hidroxilase humana

PTDC/SAU-FCF/098733/2008

Helena Maria Cabral Marques

Sistemas de libertação de fármacos baseados em cyclodextrinas para inalação

PTDC/QUI-BIQ/111411/2009

Liana Casquinha da Silva

Ceramide and Glucosylceramide impact on membrane biophysical properties: from models of plasma- and lysosomal-membranes to the cell membrane  2011-2014
ENMED/Nmed/0001/2009 Rogério Paulo Pinto de Sá Gaspar Targeting combined therapy to cancer stem cells (nanostem)
PTDC/SAU-FAR/119389/2010 Helena Isabel Fialho Florindo Roque Ferreira TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles.  2012-2015
PTDC/SAU-FAR/120453/2010 Mafalda de Castro Ascensão Marques Videira Nanopartículas lípidicas/micelares para encapsulamento de sirna como estratégia para recuperar a expressão de e-cadherina e suprimir o fenótipo tumorogénico do tumor da mama avançado
PTDC/DTP-FTO/1057/2012 João Fernandes Abreu Pinto medMilk leites medicinais em pó para administração oral de fármacos em pediatria.PTDC /BBB-BQB/0506/2012
PTDC /BBB-BQB/0506/2012 Liana Casquinha da Silva Ceramide-Platforms: implication of membrane biophysical properties on ceramide biological outcome.

 

 

 

Referência

Investigador Responsável FFULisboa

Título

Duração

PTDC/CTMNAN/2658/2014

Lídia Maria Diogo Gonçalves

Dual nanostructured lipid carriers as a multifunctional platform for brain tumor therapy 2016-2018

 PTDC/DTP-FTO/0094/2012

António José Leitão Neves Almeida

Fighting TB: Development of microparticulate systems to target alveolar macrophages in tuberculosis therapy 2012-2015

APCINTER-00284/14

João Pedro Almeida Lopes

“INOVAÇÃO FARMACÊUTICA: síntese e caracterização espectroscópica de co-cristais e deformas polifórmicas de fármacos amplamente utilizados pela população brasileira” 2014-2016

PTDC/BBB-BQB/6071/2014

 

 Liana Casquinha da Silva Organização dos esfingolípidos na membrana plasmática de Saccharomyces cerevisiae. Implicações no modo de acção de anti-fúngicos e mecanismos de resistência em fungos

PTDC/AAGTEC/4501/2014 PI

João Pedro Almeida Lopes

Impact of engineered nanoparticles and microplastics on textile wastewater treatment with aerobic granular sludge technology
PTDC/AGRPRO/6817/2014 João Pedro Almeida Lopes Grapevine cultivars metabolic modelling combining weather, soil and noninvasive insitu vibrational spectroscopy data
PTDC/BBB-BQB/6071/2014 (2016-2019) Liana Casquinha Silva RESYEAST: Sphingolipid organization in the plasma membrane of Saccharomyces cerevisiae. Implication in antifungal mode of action and fungal resistance.

DC/SAU-TOX/120953/2010

iMed.ULisboa

“Novel metabolic profiling approach for evaluating the toxicological effects of silver nanoparticles in human cells” 2011-2014

PTDC/EME-MFE/103640/2008

João Fernandes Abreu Pinto

Optimization of single- and two-phase micro-flows in extracorporeal medical devices for powder inhalation (optimed)

PTDC/QUI-QUI/098216/2008

João Fernandes Abreu Pinto

Polimorfismo em sólidos moleculares orgânicos: estrutura e energética

PTDC/QUE-EPR/099226/2008

Maria Eugénia Meirinhos da Cruz

Development of new polymer-liposome complexes combining experimental and computational approaches  2010-2013

PTDC/EQU-EQU/104318/2008

António José Leitão Neves Almeida

Controlled freezing to improve the stability and delivery of therapeutic proteins 2010-2013

PTDC/EBB-EBI/120624/2010

 João Pedro Almeida Lopes BIOTEXTILE – Biotecnologia de reactores descontínuos-sequenciais para o tratamento eficaz de águas residuais têxteis”

PTDC/SAU-MIC/111387/2009

Helena Isabel Fialho Florindo Roque Ferreira

Pre-clinical assays of a gapdh-based vaccine against group b streptococcus infection

PTDC/SAU-TOX/120953/2010

Maria Luísa Corvo

Metabolic profiling: a novel tool for evaluation of the toxicological and biological effects of nanomaterials